New Day Diagnostics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 4

New Day Diagnostics General Information

Description

Developer of non-invasive diagnostic tests intended to improve the detection of diseases. The company passionately serves and collaborates with healthcare professionals, the scientific community, and consumers alike by providing accurate, fast, and easy-to-use diagnostic tests that enable the early detection of a broad spectrum of diseases, helping health systems enhance the care they deliver with efficient and accurate tools.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 6701 Baum Drive
  • Suite 110
  • Knoxville, TN 37919
  • United States
+1 (865) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

New Day Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 15-Aug-2023 Cancelled Generating Revenue
3. Accelerator/Incubator 01-Jun-2017 000.00 Completed Generating Revenue
2. Early Stage VC 18-Aug-2016 $82.5K Completed Generating Revenue
1. Early Stage VC (Series A) 29-Jul-2016 $82.5K $82.5K Completed Generating Revenue
To view New Day Diagnostics’s complete valuation and funding history, request access »

New Day Diagnostics Patents

New Day Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3817756-A2 Bcl-2 antibodies and immunoassay for diagnosis of cancer Pending 05-Jul-2018 000000000
EP-3817756-A4 Bcl-2 antibodies and immunoassay for diagnosis of cancer Pending 05-Jul-2018 000000000 0
CA-3105726-A1 Bcl-2 antibodies and immunoassay for diagnosis of cancer Pending 05-Jul-2018 000000000
US-20220372579-A1 Methods for detecting cpg methylation and for diagnosing cancer Pending 19-Dec-2014 C12Q1/6858 0

New Day Diagnostics Executive Team (7)

Name Title Board Seat Contact Info
Eric Mayer Chief Executive Officer & Board Member
Jason Liggett Ph.D Chief Scientific Officer
Melissa Cantrell Director, Finance
Sam Libby Chief Business Officer & Head of M&A
Jason Scott Chief Commercial Officer
You’re viewing 5 of 7 executive team members. Get the full list »

New Day Diagnostics Board Members (11)

Name Representing Role Since
Autumn Anfang Self Board Member 000 0000
Chris Chandler Self Board Member 000 0000
David Allyn Self Board Member 000 0000
Eric Mayer New Day Diagnostics Chief Executive Officer & Board Member 000 0000
Navroze Mehta Self Chairman 000 0000
You’re viewing 5 of 11 board members. Get the full list »

New Day Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

New Day Diagnostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tampa Bay Technology Incubator Accelerator/Incubator Minority 000 0000 000000 0
Boma Investments Impact Investing Minority 000 0000 000000 0
Institute for Commercialization of Florida Technology Not-For-Profit Venture Capital Minority 000 0000 000000 0
Start Capital Venture Capital Minority 000 0000 000000 0
To view New Day Diagnostics’s complete investors history, request access »

New Day Diagnostics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Epigenomics 24-Jul-2023 0000000000 000.00 Diagnostic Equipment 0000 0000
EDP Biotech 05-Jul-2023 Merger/Acquisition Diagnostic Equipment 0000000 0
To view New Day Diagnostics’s complete acquisitions history, request access »

New Day Diagnostics Subsidiaries (1)

Company Name Industry Location Founded
Epigenomics Diagnostic Equipment Berlin, Germany 0000
To view New Day Diagnostics’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »